Is China Resources Sanjiu a state-owned enterprise or a central enterprise?

China Resources Sanjiu is a state-owned enterprise.

China Resources Sanjiu Pharmaceutical Co., Ltd. (hereinafter referred to as "China Resources Sanjiu") is a large state-owned pharmaceutical listed company, formerly known as Shenzhen Southern Pharmaceutical Factory. 1April 2, 9991,initiated the establishment of a joint-stock company. On March 9, 2000, it was listed on Shenzhen Stock Exchange with stock code 000999.

The company officially entered China Resources Group at the end of June 2007. On February 20 10, the company name was officially changed from "Sanjiu Pharmaceutical Co., Ltd." to "China Resources Sanjiu Pharmaceutical Co., Ltd.".

On September 23rd, 2009, 2065438+was identified by the Ministry of Education and other four departments as the first batch of national enterprise practice bases for vocational education teachers. In April, 2020, it was selected into the list of "Science and Technology Reform Demonstration Enterprises" of the State Council State-owned Assets Supervision and Administration Commission. On June 5438+February 65438+February 4, 2022, the investor interaction platform said that China Resources Sanjiu "Ibuprofen Suspension" had been approved for listing in the State Administration of Pharmaceutical Products.

Business scope of China Resources Sanjiu:

The business scope of the company when it goes public is: the development, production and sales of drugs, health care products and medical devices; Development, transfer and service of related technologies; Health care services.

200 1 was reviewed and approved by the first extraordinary general meeting of shareholders in 20001,and the business scope of the company was changed to: drug research and development, production and sales; Development, transfer and service of related technologies; Import business of machinery, equipment and raw materials needed for production; Export of self-produced products (except commodities and technologies whose import and export are restricted or prohibited by the state).

Generally speaking, it is mainly engaged in research and development, production, sales and related health services of pharmaceutical products. OTC (over-the-counter drugs), prescription drugs, non-fried Chinese medicines, antibiotics and generic drugs are the four major medical business modules, supplemented by packaging and printing, medical services and other related businesses.

Reference to the above content: Baidu Encyclopedia-China Resources Sanjiu Pharmaceutical Co., Ltd.